Sybren N. Maas

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directions.

BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directions.

Journal: Neuro-oncology

Published: March 09, 2026

BRAFV600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol.

BRAFV600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 10, 2026

Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target.

Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target.

Journal: Neuro-oncology advances

Published: January 13, 2026

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Journal: Nature communications

Published: January 09, 2026

Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas.

Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas.

Journal: Acta neuropathologica communications

Published: December 23, 2025

Analysis of anatomical location, mitoses, and Ki-67 in 2608 meningiomas.

Analysis of anatomical location, mitoses, and Ki-67 in 2608 meningiomas.

Journal: Journal of neuropathology and experimental neurology

Published: November 21, 2025

The evolving role of TERT alterations in meningioma risk stratification.

The evolving role of TERT alterations in meningioma risk stratification.

Journal: Neuro-oncology

Published: September 24, 2025

TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas.

TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas.

Journal: Cell reports. Medicine

Published: September 09, 2025

Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.

Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.

Journal: Acta neuropathologica

Published: August 26, 2025

The prognostic impact of CDKN2A/B hemizygous deletions in meningioma.

The prognostic impact of CDKN2A/B hemizygous deletions in meningioma.

Journal: Neuro-oncology

Published: August 13, 2025

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Journal: Nature cancer

Published: July 26, 2025

Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cells.

Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cells.

Journal: Acta neuropathologica

Published: July 08, 2025

Showing 1-12 of 64

Last Updated: 09/26/2026